Brokerages Anticipate Ducommun Incorporated (NYSE:DCO) Will Announce Quarterly Sales of $172.39 Million - Defense World

2022-06-10 23:51:17 By : Mr. Daosen Liao

Posted by admin on Jun 7th, 2022

Wall Street analysts expect Ducommun Incorporated (NYSE:DCO – Get Rating) to announce $172.39 million in sales for the current quarter, Zacks reports. Two analysts have provided estimates for Ducommun’s earnings. The lowest sales estimate is $170.50 million and the highest is $174.27 million. Ducommun reported sales of $160.19 million in the same quarter last year, which indicates a positive year-over-year growth rate of 7.6%. The business is expected to announce its next earnings report on Monday, January 1st.

On average, analysts expect that Ducommun will report full year sales of $703.60 million for the current financial year, with estimates ranging from $700.58 million to $706.61 million. For the next fiscal year, analysts expect that the company will report sales of $751.73 million, with estimates ranging from $747.90 million to $755.56 million. Zacks’ sales averages are an average based on a survey of sell-side analysts that that provide coverage for Ducommun.

Ducommun (NYSE:DCO – Get Rating) last announced its earnings results on Tuesday, May 3rd. The aerospace company reported $0.67 EPS for the quarter, beating analysts’ consensus estimates of $0.53 by $0.14. The business had revenue of $163.48 million during the quarter, compared to analysts’ expectations of $160.85 million. Ducommun had a net margin of 21.01% and a return on equity of 8.91%. During the same period in the prior year, the company earned $0.58 earnings per share.

Several equities research analysts have recently weighed in on the stock. TheStreet raised shares of Ducommun from a “c+” rating to a “b” rating in a research note on Tuesday, March 8th. Zacks Investment Research raised shares of Ducommun from a “sell” rating to a “hold” rating in a research report on Friday, May 6th. StockNews.com cut shares of Ducommun from a “strong-buy” rating to a “buy” rating in a report on Monday, May 9th. Finally, B. Riley lifted their target price on shares of Ducommun from $68.00 to $72.00 in a research note on Wednesday, May 4th.

Shares of NYSE:DCO opened at $45.26 on Tuesday. Ducommun has a fifty-two week low of $40.00 and a fifty-two week high of $58.18. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.93 and a current ratio of 2.94. The firm has a fifty day moving average price of $49.60 and a 200 day moving average price of $47.73. The firm has a market cap of $544.61 million, a price-to-earnings ratio of 4.05 and a beta of 1.30.

In other Ducommun news, Director Robert C. Ducommun sold 2,250 shares of the stock in a transaction on Tuesday, March 22nd. The stock was sold at an average price of $52.69, for a total value of $118,552.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Robert C. Ducommun sold 1,500 shares of the firm’s stock in a transaction on Thursday, March 24th. The shares were sold at an average price of $53.25, for a total value of $79,875.00. The disclosure for this sale can be found here. Insiders sold 13,528 shares of company stock worth $670,265 in the last ninety days. 10.80% of the stock is currently owned by corporate insiders.

Large investors have recently modified their holdings of the business. William Blair Investment Management LLC raised its holdings in shares of Ducommun by 2.2% during the 1st quarter. William Blair Investment Management LLC now owns 922,135 shares of the aerospace company’s stock valued at $48,311,000 after buying an additional 19,916 shares during the period. BlackRock Inc. boosted its position in Ducommun by 3.6% during the 1st quarter. BlackRock Inc. now owns 839,094 shares of the aerospace company’s stock worth $43,960,000 after acquiring an additional 28,819 shares during the period. Paradigm Capital Management Inc. NY lifted its holdings in shares of Ducommun by 3.3% in the first quarter. Paradigm Capital Management Inc. NY now owns 738,148 shares of the aerospace company’s stock valued at $38,671,000 after buying an additional 23,467 shares during the period. Goldman Sachs Group Inc. lifted its holdings in shares of Ducommun by 12.1% in the first quarter. Goldman Sachs Group Inc. now owns 484,867 shares of the aerospace company’s stock valued at $25,402,000 after buying an additional 52,406 shares during the period. Finally, Wellington Management Group LLP lifted its holdings in shares of Ducommun by 32.7% in the third quarter. Wellington Management Group LLP now owns 472,129 shares of the aerospace company’s stock valued at $23,772,000 after buying an additional 116,345 shares during the period. 84.20% of the stock is currently owned by hedge funds and other institutional investors.

Ducommun Company Profile (Get Rating)

Ducommun Incorporated provides engineering and manufacturing products and services primarily to the aerospace and defense, industrial, medical, and other industries in the United States. It operates through two segments, Electronic Systems and Structural Systems. The Electronic Systems segment provides cable assemblies and interconnect systems; printed circuit board assemblies; higher-level electronic, electromechanical, and mechanical components and assemblies, as well as lightning diversion systems; and radar enclosures, aircraft avionics racks, shipboard communications and control enclosures, shipboard communications and control enclosures, printed circuit board assemblies, cable assemblies, wire harnesses, interconnect systems, lightning diversion strips, surge suppressors, conformal shields, and other assemblies.

Get a free copy of the Zacks research report on Ducommun (DCO)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Ducommun Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ducommun and related companies with MarketBeat.com's FREE daily email newsletter.

Analysts Anticipate Sabra Health Care REIT, Inc. (NASDAQ:SBRA) Will Announce Quarterly Sales of $159.10 Million

Merck & Co., Inc. (NYSE:MRK) Given Outperform Rating at SVB Leerink